🔴 Cresco Labs is trading 5.72% down today after flat Q3 outlook and margin pressure

Cresco Labs is trading 5.72% down now at $0.70 after investors continued digesting August 6 earnings report.

• Q2 revenue and adjusted EBITDA exceeded expectations, but management projected roughly flat sequential Q3 revenue and warned of gross-margin pressure from higher-cost inventory and facility upgrades.
• Reported CFO departure adds leadership-transition risk; broader cannabis shares remained under pressure, while the overall market was modestly lower.
• The catalyst appears to be post-earnings caution, not a fresh August 10 announcement.